Explore our comprehensive coverage of fda approval, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The FDA's accelerated approval of a $1.2 million CRISPR base-editing therapy for Alzheimer's, coupled with emerging safety data on epigenetic drift, i...
Read Full Story →
Mental HealthThe global mental health infrastructure is fracturing under five converging crises, from biometric m...
![[Medical Research's October Reckoning: Five Breakthroughs Reshape Therapeutics, Pricing, and Patient Access]](https://www.crimaz.com/assets/images/no-image.png)
Medical Research[Five October 2026 medical breakthroughs—retatrutide approval, Alzheimer's blood test coverage, CR...
Medical ResearchThe 2026 FDA approval of an in vivo CRISPR therapy for Sanfilippo syndrome marks a historic shift in...
Public HealthThe convergence of OTC continuous glucose monitors, dynamic insurance pricing, and fragmented immuni...
Medical ResearchThe FDA's accelerated approval of AI-designed neuro-regenerative therapies and the expansion of GLP-...
Medical ResearchThe FDA's accelerated approval of a $3.2M CRISPR therapy, coupled with a rival's data manipulation a...
